by Jenny Halstead | May 9, 2024 | Latest News
This amazing news just in from our friend Dr. Scott Perry : It has been an exciting journey as PI of Swallowtail, the open label extension study for STK-001, working alongside Stoke Therapeutics to develop disease-modifying therapy for Dravet! Looking forward to...
